Trial
NCT01833065
Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Ferring Pharmaceuticals
Collaborators
—
Condition
Chronic Idiopathic Constipation
Intervention
Elobixibat 10 mg/day
Why stopped
Terminated due to a distribution issue with the trial medication
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-10-20